|
||||||||
![]() |
||||||||
![]() |
A Comprehensive Approach: Chapter 2, Section 4: References Academy for Educational Development. Comprehensive HIV prevention services for injection drug users: an assessment of state and local technical assistance issues and priorities. Washington (DC): AED; August 1999. Prepared for the Centers for Disease Control and Prevention. Academy for Educational Development. HIV prevention among drug users: a resource book for community planners and program managers. Washington (DC): Academy for Educational Development; 1997. Funding provided under Centers for Disease Control and Prevention contract number 200-91-0906. Amaro H. An expensive policy: the impact of inadequate funding for substance abuse treatment. [editorial] American Journal of Public Health 1999;89:657-659. Bluthenthal RN, Lorvick J, Kral AH, Erringer EA, Kahn JG. Collateral damage in the war on drugs: HIV risk behaviors among injection drug users. The International Journal of Drug Policy 1999;10:25-38. Breitbart V, Chavkin W, Wise P. The accessibility of drug treatment for pregnant women: a survey of programs in five cities. American Journal of Public Health 1994;84(10):1658-1661. Burris S, Lurie P, Abrahamson D, Rich JD. Physician
prescribing of sterile injection equipment to prevent HIV infection:
time for action. California Department of Alcohol and Drug Programs. Evaluating recovery services: The California Drug and Alcohol Treatment Assessment. Sacramento (CA): California Department of Alcohol and Drug Programs; 1994. Case P, Meehan T, Jones TS. Arrests and incarceration of injection drug users for syringe possession in Massachusetts: implications for HIV prevention. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998;18(Suppl 1):S71-S75. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP. Limbic activation during cue-induced cocaine craving. American Journal of Psychiatry 1999;156(1):11-18. Cole FL, Slocumb EM. Nurses' attitudes toward patients with AIDS. Journal of Advanced Nursing 1993;18:1112-1117. Des Jarlais DC, Friedman SR, Ward TP. Harm reduction: a public health response to the AIDS epidemic among injecting drug users. Annual Reviews of Public Health 1993;14:413-450. Epstein J, Gfroerer J. Changes
affecting NHSDA estimates of treatment need for 1994-1996. Friedman SR. The political economy of drug-user scapegoating-and the philosophy and politics of resistance. Drugs: Education, Prevention, and Policy 1998;5(1):15-32. Gostin LO. The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18(Suppl 1):S60-S70. Jones TS, Anderson T. "Junkiephobia": a new concept to capture the stigma and ostracism of drug users and limitations on HIV prevention for drug users. Poster presented at National HIV Prevention Conference, Atlanta (GA), August 29-September 1, 1999. Jones TS, Taussig J. Should pharmacists sell sterile syringes to injection drug users? Journal of the American Pharmaceutical Association 1999;39(1):8-10. Koester SK. Copping, running, and paraphernalia laws: contextual and needle risk behavior among injection drug users in Denver. Human Organization 1994;53:287-295. Koob GF. Drugs of abuse: anatomy, pharmacology, and function of reward pathways. Trends in Pharmacological Sciences. 1992;13:177-184. Koob GF. Drug addiction: the yin and yang of hedonic homeostatis. Neuron. 1996;16(5):893-896. Leshner A. Why shouldn't society treat substance abusers? Los Angeles Times. June 11, 1999. Leshner AI. Addiction is a brain disease and it matters. Science 1997;278:45-47. Lorvick J, Bluthenthal R, Kral AH. The
withdrawal of SSI disability benefits for drug and alcohol addiction. McGrory BJ, McDowell DM, Muskin PR. Medical students' attitudes toward AIDS, homosexual, and intravenous drug-abusing patients: a re-evaluation in New York City. Psychosomatics 1990;31(4):426-433. National Institute on Drug Abuse (NIDA) and Hospital Practice. New understanding of drug addiction. Proceedings from a symposium cosponsored by the National Institute on Drug Abuse (NIDA) and Hospital Practice. Minneapolis (MN): McGraw Hill Healthcare Information Programs; April 1997. National Institutes of Health (NIH). Effective medical treatment of opiate addiction. NIH Consensus Statement. 1997, November 17-19;15(6):1-38. O'Brien CP, McLellan AT. Myths about the treatment of addiction. Lancet 1996;347:237-240. Rydell CP, Everingham SMS. Controlling cocaine: supply versus demand programs. Santa Monica (CA): RAND Corporation; 1994. U.S.General Accounting Office (GAO). Women in
prison: issues and challenges confronting U.S. correctional systems.
Washington (DC):GAO; 1999. GAO Report No.:GGD-00-22. www.gao.gov U.S. House of Representatives. Prohibiting the expenditure of federal funds for distribution of needles or syringes for hypodermic injection of illegal drugs. Congressional Record-House. April 29, 1998, H2445-H2478. Volkow ND, Fowler JS, Wang G-J, Hitzemann R, Logan J, Schulyer D, Dewey S, Wolf AP. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993;14:169-177. Wallack JJ. AIDS and the health care professional: evolving attitudes and strategies to effect change. Psychiatric Medicine 1991;9(3):483-501. Wren C. Top U.S. drug official proposes shift in criminal justice policy. The New York Times. December 9, 1999. Yedidia MJ, Barr, JK, Berry CA. Physicians' attitudes toward AIDS at different career stages:a comparison of internists and surgeons. Journal of Health and Social Behavior 1993;34:272-284. Yedidia MJ, Berry CA, Barr, JK. Physicians' attitudes toward AIDS during residency training: a longitudinal study of medical school graduates. Journal of Health and Social Behavior 1996;37:179-191.
This CDC Web site is no longer being reviewed or updated and thus is no longer kept current. This site remains to assist researchers or others needing historical content. |
||||||||||||||||||||||||